Press releases
- Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
- Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
- Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
- Bicycle Therapeutics to Participate in Upcoming Investor Conferences
- Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
On Friday, Bicycle Therapeutics PLC (50BA:DUS) closed at 19.60, 0.51% above its post-IPO low of 19.50, set on May 15, 2024.
52-week range
Open | 19.80 |
---|---|
High | 19.90 |
Low | 19.60 |
Bid | 19.50 |
Offer | 19.80 |
Previous close | 19.90 |
Average volume | 0.00 |
---|---|
Shares outstanding | 42.78m |
Free float | 4.33m |
P/E (TTM) | -- |
Market cap | 948.84m USD |
EPS (TTM) | -4.45 USD |
Data delayed at least 15 minutes, as of May 17 2024 18:32 BST.
More ▼